Open AccessThe Skeletal Consequences of Growth Hormone Therapy in Dialyzed Children
Author(s) -
Justine Bacchetta,
Katherine WesselingPerry,
Beatriz D. Kuizon,
Renata Péreira,
Barbara Gales,
He-Jing Wang,
Robert M. Elashoff,
Isidro B. Salusky
Publication year - 2013
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.00330112
Subject(s) - medicine , bone remodeling , renal osteodystrophy , parathyroid hormone , interquartile range , bone age , endocrinology , hyperparathyroidism , biopsy , urology , gastroenterology , calcium , kidney disease
The effects of recombinant human growth hormone on renal osteodystrophy are unknown; thus, the effects of growth hormone (GH) on bone histomorphometry were assessed in pediatric patients with ESRD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom